Development of complement C5a and its receptor in malignant tumour cells as mammary tumour biomarker
Mammary cancer is the most common disease among women and second cause of female mortality related to cancer. The relationship between immune system and mammary cancer is still questionable. C5a is an important chemotactic protein that is recognized as an anaphylatoxin and chemoattractant that exert...
Saved in:
Main Author: | Ganti, Norhaifa |
---|---|
Format: | Thesis |
Language: | English |
Published: |
2015
|
Subjects: | |
Online Access: | http://psasir.upm.edu.my/id/eprint/70855/1/FPV%202015%202%20IR.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Modulation of C5A receptor in mammary gland tumour by EP54 and PMX205 peptides
by: Kosni, Nurneqman Nashreq
Published: (2015) -
Regression mouse mammary tumour through complement-mediated inflammation of C5A/C5AR axis
by: Kamarudin, Nurul Hazwani
Published: (2015) -
Expression and identification of C5a and its receptor (C5aR) as a diagnostic marker for benign mammary tumour
by: Bachek, Noor Farhana
Published: (2016) -
Clinicopathological assessment of intramammary administration of genetically engineered Salmonella Agona (4KA32) in domestic dogs
by: Rajendren, Sujey Kumar
Published: (2017) -
Biodistribution of poly-L-glutamic acid-[5-3H]-2'- deoxyctidine in mice bearing mammary tumour /
by: Ernidila Ramli
Published: (2012)